Medicine

Should Copay Accumulators be Banned? Pharmatizing AI & more

Check out our conference coverage of

Patient Assistance & Access Programs (PAP) and Hub and Specialty Models East

Pharmatizing AI

Using the 3 Rs to guide AI transformation in Pharma.

Should copay accumulators be banned?

An increasing number of patients are receiving copay assistance from drug manufacturers and others to help cover the cost of expensive medications. Until fairly recently, the funding from those programs, which can easily run into the thousands of dollars per year, did not count toward a patient’s deductible or out-of-pocket maximum. As a result, a fair number of patients paid very little if anything out of pocket for expensive drugs.

Oprah delves into GLP-1 drugs, obesity-shaming

The primetime special from Oprah Winfrey examined the rise of GLP-1 drugs like Ozempic and Mounjaro as well as the need to do away with obesity shaming.

Talkspace Launches Health Collective to Further Expand Accessibility to Healthcare Services

Talkspace announced the launch of Health Collective, a new wellness ecosystem featuring Oura, Evernow, Bicycle Health, Conceive, Options MD, and more. The platform will provide members with vetted and curated resources, and member benefits across the entire health spectrum, with the goal of expanding accessibility to high-quality and holistic care.

Sanofi on X:

We’re all in on AI. In a conversation with @TEDTalks, our CEO Paul Hudson shared its time for businesses to harness AI to achieve the extraordinary. Watch to learn more: http://spkl.io/60184Loce

#RepsonsibleAI #Innovation #TEDTalks

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

Leave a Reply

Your email address will not be published. Required fields are marked *